PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Quantifying barriers to establishing sequestration wells

A new study aims to reduce the time required to implement geologic sequestration sites for carbon capture

Quantifying barriers to establishing sequestration wells
2023-12-18
(Press-News.org) Carbon capture and sequestration (CCS), the process of capturing and storing atmospheric carbon dioxide, is one method of reducing the amount of carbon dioxide in the atmosphere in efforts to reduce the impacts of climate change. While CCS is an essential tool in decarbonizing the U.S. economy, there are barriers that exist to the development, approval, and implementation of a geologic sequestration site, as it requires an appropriate geologic formation, as well as an approved injection facility.

Recent work from the Carnegie Mellon University Department of Engineering and Public Policy (EPP) estimates the time required to develop, approve, and implement a geologic sequestration site in the U.S. by identifying six clearance points that must be passed for a site to become operational and provides insights into how this timeframe could be reduced.

The clearance points identified include: time to find site(s), time to prepare selected site, time for EPA approval, time to resolve any legal challenge, time to construct well and pipeline, and time for injection authorization. By seeking input from experts on each clearance point, Ph.D. student Emily Moore and faculty members Valerie Karplus and Granger Morgan combined expert judgements in a simulation framework to project timeframes within which these points could be cleared.

“Understanding the many steps and expected timeframes is an essential starting point to assess what needs to happen if society wants to deploy carbon capture and sequestration as a decarbonization solution,” says Karplus. “It is unlikely that timing written into regulatory processes for key steps will be realized in practice, so we turned to experts for their views.”

The findings indicate that on average, there is a 90% probability that the time required for a site to become operational is between 5.5 and 9.6 years, with an upper bound of 12 years. Even using the most optimistic expert judgements, the lower bound is 2.7 years, and the upper bound is 8.3 years.

These estimates show that strategies must be implemented to accelerate the process if CCS is to have a meaningful impact toward the nation’s 2050 climate goals. This is particularly critical if projects are to be eligible for the Section 45Q CCS tax credit under the Inflation Reduction Act, which expires in 2032, well before the upper bound estimate of 12 years. The authors put forth seven recommendations that could speed the time for sites to be utilized.

The clearance points that were estimated to cause the longest non-technical delays included pore space acquisition, the Class VI permit application review process, and potential litigation, and as such the recommendations address these obstacles.

Currently only North Dakota and Wyoming have Class VI primacy, which allows these states to expedite their application process. By granting states primacy, there is potential to speed up the permitting process, and legislative efforts could be feasible to facilitate these endeavors. Additionally, legal frameworks could be developed to reduce litigation and proactively engage communities where sites are being developed.

“Prior work has suggested that public acceptance is essential for emerging technologies to reach wider application,” said Moore. “Our research suggests that court challenges could extend time frames substantially. Engaging the public, along with treating landowners as important stakeholders, could go a long way toward mitigating the risk of protracted delays.”

Over a decade ago, recognizing that the U.S. would soon need CCS to decarbonize the nation’s energy system, Morgan and colleagues at Carnegie Mellon led a team of technical and legal experts that developed a comprehensive approach that addressed key issues, including ownership of the deep subsurface, learning from experience, and long-term stewardship and liability. The project’s recommendations and resulting book were widely distributed to members of Congress and other key decision makers.

Reflecting on this earlier work, Morgan observes, “Back then, decarbonizing the energy system was not on the top of most policy agendas, so we have ended up with a piecemeal system that addresses only a part of the problem on a state-by-state basis. While that’s better than nothing, we need to accelerate the process and make sure that issues such as liability and long-term stewardship are appropriately addressed.”

END

[Attachments] See images for this press release:
Quantifying barriers to establishing sequestration wells

ELSE PRESS RELEASES FROM THIS DATE:

Sylvester cancer researcher and technology innovator named fellow of the National Academy of Inventors

Sylvester cancer researcher and technology innovator named fellow of the National Academy of Inventors
2023-12-18
MIAMI, FLORIDA (Dec. 18, 2023) – Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has been named a fellow of the National Academy of Inventors. Her research focuses on ways to overcome barriers to precisely target mitochondria – the part of each cell that generates the energy needed for biochemical reactions. Her inventions and innovative contributions in nanomedicine, mitochondria-targeted drug delivery, and platinum-based prodrugs help guide targeted therapies in cancer and other diseases. Dhar, an associate professor of biochemistry and molecular biology ...

Team led by UMASS Amherst discovers how to sabotage antibiotic-resistant ‘superbugs’

Team led by UMASS Amherst discovers how to sabotage antibiotic-resistant ‘superbugs’
2023-12-18
Antibiotic-resistant “superbugs” that can defeat efforts to kill them are an urgent public health crisis, and according to the Centers for Disease Control, more than 2.8 million antibiotic-resistant infections occur each year. Researchers across the world are scrambling to meet the challenge. A collaborative team of researchers led by the University of Massachusetts Amherst and including scientists from the biopharmaceutical company Microbiotix recently announced that they had successfully learned how to sabotage a key piece of machinery that pathogens use to infect their host cells, and have developed a test to identify the next-generation drugs ...

How effective are opioid medications for cancer pain?

2023-12-18
Researchers examining the data on opioids for pain caused by cancer have found surprisingly large gaps in evidence regarding the true benefits of these medicines for cancer pain. The review challenges the commonly held view that opioids are the most powerful pain relievers. The University of Sydney-led review highlights there is no ‘one size fits all’ treatment approach for cancer pain, urging health professionals and patients to carefully weigh up the evidence when deciding on a suitable pain management plan. Opioid pain relievers are the most common treatment for cancer pain management. Many international guidelines including the ...

Firearms and hanging top methods for suicide in US as rates continue to rise

2023-12-18
Embargoed for release until 5:00 p.m. ET on Monday 18 December 2023   Annals of Internal Medicine Tip Sheet    @Annalsofim   Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.   ----------------------------   1. ...

B cell deficient patients gain protective T cell immunity following SARS-CoV-2 vaccination and infection, study finds

2023-12-18
B cell deficiency is a common condition that can result either from immunosuppressant drugs used to treat autoimmune disease or certain cancers — such as rituximab (RTX) — or from natural immune deficiency. These patients suffer from a weakened immune system that is less effective at combating both viral and bacterial diseases. As B cells are a key type of immune cell that produces antibodies, a deficiency results in a significant decrease in antibody count that can lead to severe disease or death upon infection with SARS-CoV-2. Researchers at the Ragon Institute of Mass General, MIT, and ...

New guidelines released for practitioners treating anaphylaxis and atopic dermatitis

2023-12-18
ARLINGTON HEIGHTS, Ill. – (December 18, 2023) — Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in pediatric and adult patients. The Joint Task Force is a partnership between the American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, Asthma and Immunology. “Both anaphylaxis and atopic dermatitis are allergic conditions that affect millions of people – in the United States and around the world,” says allergist Jay Lieberman, MD, co-chair of the JTFPP ...

Spike in dermatology visits for skin problems seen during summer of wildfires

2023-12-18
New research suggests that air pollution may contribute to the development or worsening of skin conditions. The work, which is published in Dermatology and Therapy and led by scientists at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system, points to the need to improve air quality to lower the burden of skin disease, especially for vulnerable communities. “We were inspired to investigate the relationship between air pollution and skin inflammation after listening to patients who kept telling us that their skin conditions like eczema were particularly bad, and in some cases ‘worse than ever before,’ this summer,” ...

Melatonin and carcinogenesis in mice: The 50th anniversary of relationships

Melatonin and carcinogenesis in mice: The 50th anniversary of relationships
2023-12-18
“[...] murine models proved to be valuable and, in some cases, indispensable for advancing melatonin applications in oncology [...].” BUFFALO, NY- December 18, 2023 – A new research perspective was published in Oncotarget's Volume 14 on December 12, 2023, entitled, “Melatonin and carcinogenesis in mice: the 50th anniversary of relationships.” Fifty years ago, in 1973, Vladimir N. Anisimov and coauthors demonstrated for the first time an inhibitory effect of the pineal ...

Yale study finds “Forever chemicals” promote cancer migration

2023-12-18
New Haven, Conn. — In a new study by researchers at the Yale School of Public Health, two “forever chemicals” spurred cancer cells in the lab to migrate to new positions, an indication that the chemicals could contribute to cancer metastasis in living organisms. The study addressed the group of industrial chemicals called per- and polyfluoroalkyl substances (PFAS). The substances are known as “forever chemicals” because they don’t break down in the environment and can build up in the human body. They have the ability to shed water and resist penetration by oils. They are ...

New survey: 79% of survey respondents overlook their health needs during the holidays; find the holidays more stressful than tax season

2023-12-18
Survey Highlights: A majority of Americans (51%) say it takes them weeks to feel less stressed after the holidays, with more than a quarter of moms reporting it takes them a month or more to recover. 71% of respondents say that their biggest regret after the holidays is that they did not take the time to relax and enjoy the season. Overall, respondents (63%) claimed that the holiday season is more stressful than tax season. Eating healthy (69%), exercising regularly (64%), and getting enough sleep (56%) are the top three things that respondents have trouble prioritizing during the holiday season. 79% of people surveyed agree that, during the holidays, they are so focused on creating special ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Quantifying barriers to establishing sequestration wells
A new study aims to reduce the time required to implement geologic sequestration sites for carbon capture